Apremilast
A PDE4 inhibitor tablet that helps reduce joint swelling, pain, and plaque psoriasis scaling.
🧴 Clinical Application
Take oral tablet twice daily. Can be taken with or without food.
⚠️ Side Effects
Diarrhea, nausea, upper respiratory tract infection, and weight loss.
🛡️ Safety Warnings
Monitor weight. Can cause depression or suicidal thoughts. Inform doctor of mood changes.
Jan Aushadhi Products containing Apremilast
Found 3 generic formulation(s) containing this active ingredient.
Apremilast Tablets 10mg
Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.
Apremilast Tablets 20mg
Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.
Apremilast Tablets 30mg
Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Apremilast.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Apremilast Tablets 10mg | 10's | ₹75.00 | APREZO, APRAIZE, APRETAS, APXENTA | ₹196.15 | 62% Save |
| Apremilast Tablets 20mg | 10's | ₹93.75 | APREZO, APRIZA | ₹246.66 | 62% Save |
| Apremilast Tablets 30mg | 10's | ₹129.38 | APREZO | ₹328.95 | 61% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Apremilast generics.